HomeAI · summaries
Storia in 2 fonti
FDA Panel Backs Wider Access To Six Peptide Therapies, Citing Grey Market Concerns
Peptides are short chains of amino acids that help regulate metabolism, growth and tissue repair...
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Six wellness peptides win backing from FDA advisory committee, setting up future agency action
FDA advisory panel voted to lift restrictions on peptides BPC-157, TB-500, KPV, MOTS-c, epitalon & semax, backed by RFK Jr., despite FDA staff safety concerns.
- ·
The future of gray-market peptides
FDA advisory panel voted to allow compounding pharmacies to make 6 of 7 peptides, despite safety/efficacy concerns, with Revelation Pharma's Shawn Hodges cautiously optimistic.
